NCT04367246View on ClinicalTrials.gov

Li-Fraumeni Syndrome/TP53 Biobank

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 24, 2019

Primary Completion Date

September 24, 2029

Study Completion Date

September 24, 2029

Conditions
Li-Fraumeni SyndromeLi-Fraumeni-Like Syndrome
Interventions
OTHER

No Intervention

No intervention is assigned.

Trial Locations (2)

19104

RECRUITING

University of Pennsylvania, Philadelphia

RECRUITING

Children's Hospital of Philadelphia, Phildelphia

All Listed Sponsors
collaborator

Children's Hospital of Philadelphia

OTHER

lead

Abramson Cancer Center at Penn Medicine

OTHER